Aurelien Delluc, Elisabeth Pasquier, Luc de Saint Martin, Dominique Mottier. Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use..
Haematologica, Ferrata Storti Foundation, 2006, 91 (3), pp.ECR05.
⟨hal-00689153⟩